TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Novartis Sverige AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,327,294
|
1,165,183
|
1,197,471 |
Financial expenses |
8,134
|
6,106
|
4,613 |
Earnings before taxes |
38,138
|
41,279
|
47,722 |
EBITDA |
47,430
|
49,173
|
54,288 |
Total assets |
498,680
|
467,207
|
436,875 |
Current assets |
489,368
|
457,221
|
424,501 |
Current liabilities |
229,143
|
216,600
|
211,432 |
Equity capital |
88,578
|
66,891
|
83,145 |
- share capital |
3,358
|
3,341
|
3,636 |
Employees (average) |
189
|
206
|
216 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
17.8%
|
14.3%
|
19.0% |
Turnover per employee |
7,023
|
5,656
|
5,544 |
Profit as a percentage of turnover |
2.9%
|
3.5%
|
4.0% |
Return on assets (ROA) |
9.3%
|
10.1%
|
12.0% |
Current ratio |
213.6%
|
211.1%
|
200.8% |
Return on equity (ROE) |
43.1%
|
61.7%
|
57.4% |
Change turnover |
156,111
|
64,708
|
-4,332 |
Change turnover % |
13%
|
6%
|
0% |
Chg. No. of employees |
-17
|
-10
|
-12 |
Chg. No. of employees % |
-8%
|
-5%
![]() |
-5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.